中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共2条，第1-2条 帮助

已选(0)清除 条数/页：   排序方式：
The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma 期刊论文
BLOOD, 2021, 卷号: 138
作者:  Ding, Kaiyang;  Shi, Xiao;  Yang, Haiyan;  Cao, Lei;  Zhao, Xiaoli;  Liu, Hailing;  Wu, Wei;  Zhang, Xiaoyan;  Wang, Li;  Xu, Wei;  Zhu, Huayuan;  Li, Jianyong;  Fan, Lei
收藏  |  浏览/下载：42/0  |  提交时间：2022/12/23
Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30
-
收藏  |  浏览/下载：33/0  |  提交时间：2020/10/26
PHASE-I  POSTMENOPAUSAL WOMEN  HDAC INHIBITOR  MULTICENTER  ENTINOSTAT  TAMOXIFEN  CS055/HBI-8000  RESISTANCE  LETROZOLE  TRIAL  Advanced breast cancer  hormone receptor-positive  chidamide  exemestane